China Resources Medical Holdings Company Ltd
HKEX:1515
China Resources Medical Holdings Company Ltd
Cost of Revenue
China Resources Medical Holdings Company Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
China Resources Medical Holdings Company Ltd
HKEX:1515
|
Cost of Revenue
-¥8.2B
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-28%
|
|
H
|
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
|
Cost of Revenue
-¥2.2B
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
Cost of Revenue
-¥9.5B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-25%
|
X
|
XiAn International Medical Investment Co Ltd
SZSE:000516
|
Cost of Revenue
-¥3.9B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-3%
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
Cost of Revenue
-¥1.7B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
Cost of Revenue
-¥836.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is China Resources Medical Holdings Company Ltd's Cost of Revenue?
Cost of Revenue
-8.2B
CNY
Based on the financial report for Dec 31, 2023, China Resources Medical Holdings Company Ltd's Cost of Revenue amounts to -8.2B CNY.
What is China Resources Medical Holdings Company Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-28%
Over the last year, the Cost of Revenue growth was -24%. The average annual Cost of Revenue growth rates for China Resources Medical Holdings Company Ltd have been -57% over the past three years , -44% over the past five years , and -28% over the past ten years .